Ketoconazole - HRA Pharma

Drug Profile

Ketoconazole - HRA Pharma

Alternative Names: Ketoconazole HRA

Latest Information Update: 24 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator HRA Pharma
  • Class Antifungals; Azoles; Piperazines; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cushing syndrome
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cushing syndrome

Most Recent Events

  • 24 Mar 2017 No recent reports of development identified - Registered for Cushing's syndrome (In adolescents, In adults) in Norway, Liechtenstein, Iceland (PO)
  • 17 Apr 2016 Biomarkers information updated
  • 19 Nov 2014 Registered for Cushing's syndrome (In adolescents, In adults) in European Union, Iceland, Liechtenstein and Norway (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top